Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

928 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cardiac cachexia: a systematic overview.
von Haehling S, Lainscak M, Springer J, Anker SD. von Haehling S, et al. Pharmacol Ther. 2009 Mar;121(3):227-52. doi: 10.1016/j.pharmthera.2008.09.009. Epub 2008 Nov 14. Pharmacol Ther. 2009. PMID: 19061914 Review.
The cardiac component of cardiac cachexia.
Florea VG, Henein MY, Rauchhaus M, Koloczek V, Sharma R, Doehner W, Poole-Wilson PA, Coats AJ, Anker SD. Florea VG, et al. Am Heart J. 2002 Jul;144(1):45-50. doi: 10.1067/mhj.2002.123314. Am Heart J. 2002. PMID: 12094187
Cardiac cachexia in early literature: a review of research prior to Medline.
Doehner W, Anker SD. Doehner W, et al. Int J Cardiol. 2002 Sep;85(1):7-14. doi: 10.1016/s0167-5273(02)00230-9. Int J Cardiol. 2002. PMID: 12163205
The syndrome of cardiac cachexia.
Anker SD, Sharma R. Anker SD, et al. Int J Cardiol. 2002 Sep;85(1):51-66. doi: 10.1016/s0167-5273(02)00233-4. Int J Cardiol. 2002. PMID: 12163209 Review.
Cytokines, apoptosis and cachexia: the potential for TNF antagonism.
Sharma R, Anker SD. Sharma R, et al. Int J Cardiol. 2002 Sep;85(1):161-71. doi: 10.1016/s0167-5273(02)00244-9. Int J Cardiol. 2002. PMID: 12163221 Review.
Statins and the role of nitric oxide in chronic heart failure.
von Haehling S, Anker SD, Bassenge E. von Haehling S, et al. Heart Fail Rev. 2003 Jan;8(1):99-106. doi: 10.1023/a:1022103222857. Heart Fail Rev. 2003. PMID: 12652163 Review.
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.
Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S. Anker SD, et al. Lancet. 2003 Mar 29;361(9363):1077-83. doi: 10.1016/S0140-6736(03)12892-9. Lancet. 2003. PMID: 12672310
Meanfollow-up was 35 months (SD 13). We analysed the effect of weight loss at cutpoints of 5%, 7.5%, 10%, 15% (a priori), and 6% (post hoc) to identify which one best predicted outcome. ...
Meanfollow-up was 35 months (SD 13). We analysed the effect of weight loss at cutpoints of 5%, 7.5%, 10%, 15% (a priori), and 6% (pos …
Studies on apoptosis and fibrosis in skeletal musculature: a comparison of heart failure patients with and without cardiac cachexia.
Filippatos GS, Kanatselos C, Manolatos DD, Vougas B, Sideris A, Kardara D, Anker SD, Kardaras F, Uhal B. Filippatos GS, et al. Int J Cardiol. 2003 Jul;90(1):107-13. doi: 10.1016/s0167-5273(02)00535-1. Int J Cardiol. 2003. PMID: 12821225
928 results
Jump to page
Feedback